Literature DB >> 21724446

Effects of parkinsonism on health status in welding exposed workers.

Rachel C Harris1, Jessica I Lundin, Susan R Criswell, Angela Hobson, Laura M Swisher, Bradley A Evanoff, Harvey Checkoway, Brad A Racette.   

Abstract

BACKGROUND: Previous studies suggest that welders frequently display parkinsonian signs, such as bradykinesia and tremor. Demonstrating that these parkinsonian findings are associated with reductions in quality of life (QoL) or health status could have important repercussions for worker safety and performance.
METHODS: Subjects included 394 active workers exposed to welding fumes and evaluated for parkinsonism by movement disorders experts in a worksite-based epidemiology study. Subjects were diagnosed with parkinsonism if the Unified Parkinson Disease Rating Scale motor subsection part 3 (UPDRS3) score was ≥15. All subjects completed a Parkinson's disease (PD) symptom questionnaire and the PDQ39, a widely used QoL and health status measure for PD.
RESULTS: Total PDQ39 score and all subscores were greater in welders with parkinsonism than welders without parkinsonism, with the most significant differences observed for mobility, emotional well-being, and activities of daily living (ADL's). The PDQ39 scores for welding exposed workers with parkinsonism were similar to scores seen in a group of early PD patients.
CONCLUSION: Parkinsonism in active, welding exposed workers is associated with reductions in health status and QoL affecting a broad range of categories and within the range seen in early PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21724446      PMCID: PMC3200492          DOI: 10.1016/j.parkreldis.2011.05.021

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  Manganese exposure in steel smelters a health hazard to the nervous system.

Authors:  A Wennberg; A Iregren; G Struwe; G Cizinsky; M Hagman; L Johansson
Journal:  Scand J Work Environ Health       Date:  1991-08       Impact factor: 5.024

2.  Quality of life and mental illness. Reflections from the perspective of the WHOQOL.

Authors:  J Orley; S Saxena; H Herrman
Journal:  Br J Psychiatry       Date:  1998-04       Impact factor: 9.319

3.  An exploratory study of manganese exposure to welders.

Authors:  S V Chandra; G S Shukla; R S Srivastava; H Singh; V P Gupta
Journal:  Clin Toxicol       Date:  1981-04       Impact factor: 4.467

4.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

Authors:  Harvey Checkoway; Karen Powers; Terri Smith-Weller; Gary M Franklin; W T Longstreth; Phillip D Swanson
Journal:  Am J Epidemiol       Date:  2002-04-15       Impact factor: 4.897

5.  Measuring symptom change in patients with Parkinson's disease.

Authors:  J E Harrison; S Preston; S B Blunt
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

6.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

7.  Nervous system dysfunction among workers with long-term exposure to manganese.

Authors:  D Mergler; G Huel; R Bowler; A Iregren; S Bélanger; M Baldwin; R Tardif; A Smargiassi; L Martin
Journal:  Environ Res       Date:  1994-02       Impact factor: 6.498

8.  Relationships of job and some individual characteristics to occupational injuries in employed people: a community-based study.

Authors:  Ashis Bhattacherjee; Nearkasen Chau; Carmen Otero Sierra; Bernard Legras; Lahoucine Benamghar; Jean-Pierre Michaely; Apurna Kumar Ghosh; Francis Guillemin; Jean-François Ravaud; Jean-Marie Mur
Journal:  J Occup Health       Date:  2003-11       Impact factor: 2.708

9.  Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile.

Authors:  Peter Hagell; Diane Whalley; Stephen P McKenna; Olle Lindvall
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

10.  Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices.

Authors:  H Roels; R Lauwerys; J P Buchet; P Genet; M J Sarhan; I Hanotiau; M de Fays; A Bernard; D Stanescu
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

View more
  11 in total

1.  Physicochemical properties of air discharge-generated manganese oxide nanoparticles: Comparison to welding fumes.

Authors:  Larissa V Stebounova; Natalia I Gonzalez-Pech; Thomas M Peters; Vicki H Grassian
Journal:  Environ Sci Nano       Date:  2018-01-15

2.  Neuromythology of Manganism.

Authors:  Kristin M Andruska; And Brad A Racette
Journal:  Curr Epidemiol Rep       Date:  2015-06

3.  Increased risk of parkinsonism associated with welding exposure.

Authors:  Brad A Racette; Susan R Criswell; Jessica I Lundin; Angela Hobson; Noah Seixas; Paul T Kotzbauer; Bradley A Evanoff; Joel S Perlmutter; Jing Zhang; Lianne Sheppard; Harvey Checkoway
Journal:  Neurotoxicology       Date:  2012-09-03       Impact factor: 4.294

4.  A screening tool to detect clinical manganese neurotoxicity.

Authors:  Brad A Racette; Anat Gross; Susan R Criswell; Harvey Checkoway; Susan Searles Nielsen
Journal:  Neurotoxicology       Date:  2017-03-06       Impact factor: 4.294

5.  Pathophysiology of manganese-associated neurotoxicity.

Authors:  Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng
Journal:  Neurotoxicology       Date:  2011-12-21       Impact factor: 4.294

Review 6.  Manganism in the 21st century: the Hanninen lecture.

Authors:  Brad A Racette
Journal:  Neurotoxicology       Date:  2013-10-19       Impact factor: 4.294

7.  Screening for early detection of parkinsonism using a self-administered questionnaire: a cross-sectional epidemiologic study.

Authors:  Jessica I Lundin; Harvey Checkoway; Susan R Criswell; Angela J Hobson; Rachel C Harris; Laura M Swisher; Bradley A Evanoff; Brad A Racette
Journal:  Neurotoxicology       Date:  2013-09-12       Impact factor: 4.294

8.  Dose-dependent progression of parkinsonism in manganese-exposed welders.

Authors:  Brad A Racette; Susan Searles Nielsen; Susan R Criswell; Lianne Sheppard; Noah Seixas; Mark N Warden; Harvey Checkoway
Journal:  Neurology       Date:  2016-12-28       Impact factor: 9.910

Review 9.  Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery.

Authors:  Gurwattan S Miranpuri; Lauren Kumbier; Angelica Hinchman; Dominic Schomberg; Anyi Wang; Hope Marshall; Ken Kubota; Chris Ross; Karl Sillay
Journal:  Ann Neurosci       Date:  2012-07

10.  Validation of Parkinson's Disease-Related Questionnaires in South Africa.

Authors:  Gill Nelson; Ntombizodwa Ndlovu; Nicola Christofides; Tintswalo M Hlungwani; Irene Faust; Brad A Racette
Journal:  Parkinsons Dis       Date:  2020-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.